GYNOSTEMMA PENTAPHYLLUM-CONTAINING HEALTH CARE PHARMACEUTICAL COMPOSITION FOR PREVENTING HYPERLIPIDEMIA, HYPERTENSION, HYPERGLYCEMIA AND GOUT

• US 20190070240A1
• Filed: 11/08/2018
• Published: 03/07/2019
• Est. Priority Date: 05/09/2016
• Status: Abandoned Application

• Current Assignee: Qirun Xie, Shaoke Wang, Zhao Zhang
• Original Assignee: Qirun Xie, Shaoke Wang, Zhao Zhang
• Inventors: WANG, Shaoke, TSE, Theresa Y Y, ZHANG, Zhao, DOU, Ping, XU, Jingrui, TIAN, Hongwei, ZHANG, Wanyu
• Application Number:
  US16/184,286
• Publication Number:
  US 20190070240A1
• Time in Patent Office: Days
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 36/185 Magnoliopsida (dicotyledons)
• CPC Class Codes: A61K 36/424 Gynostemma
• CPC Class Codes: A61K 36/46 Eucommiaceae (Eucommia family), e.g. hardy rubber tree
• CPC Class Codes: A61K 36/488 Pueraria (kudzu)
• CPC Class Codes: A61K 36/605 Morus (mulberry)
• CPC Class Codes: A61K 36/68 Plantaginaceae (Plantain Family)
• CPC Class Codes: A61K 36/739 Sanguisorba (burnet)
• CPC Class Codes: A61K 36/899 Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
• CPC Class Codes: A61K 9/14 Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51
• CPC Class Codes: A61K 9/20 Pills, tablets, discs, rods A61K9/0004, A61K9/0007, A61K9/0056, A61K9/0065 take precedence; for reconstitution of a drink A61K9/0095
• CPC Class Codes: A61P 19/02 for joint disorders, e.g. arthritis, arthrosis

Abstract

A gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout is prepared by mixing raw materials of gynostemma pentaphyllum, folium eucommiae, folium mori, semen plantaginis, herba lophatheri, pueraria mirifica powder, pelargonium graveolens and sanguisorba minor, and the raw materials are in percentage by mass: 40-70% of gynostemma pentaphyllum, 5-20% of folium eucommiae, 5-20% of folium mori, 5-10% of semen plantaginis, 2-10% of herba lophatheri, 2-10% of pueraria mirifica powder, 2-8% of pelargonium graveolens and 2-8% of sanguisorba minor. The gynostemma pentaphyllum is prepared by mixing diploid gynostemma pentaphyllum leaves and tetraploid gynostemma pentaphyllum leaves according to a ratio. The pharmaceutical composition is mainly aimed at people who suffer from hyperlipidemia, hypertension, hyperglycemia and hyperuricemia, and used for preventing and treating the “four hypers

Claims

1. A gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout, prepared by mixing raw materials of gynostemma pentaphyllum, folium eucommiae, folium mori, semen plantaginis, herba lophatheri, pueraria mirifica powder, pelargonium graveolens and sanguisorba minor, wherein the raw materials are in percentage by mass:

40-70% of gynostemma pentaphyllum, 5-20% of folium eucommiae, 5-20% of folium mori, 5-10% of semen plantaginis, 2-10% of herba lophatheri, 2-10%0/of pueraria mirifica powder, 2-8% of pelargonium graveolens and 2-8% of sanguisorba minor.

2. The gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout according to claim 1, wherein the pharmaceutical composition is prepared by mixing the following raw materials in percentage by mass:

50-70% of gynostemma pentaphyllum, 6-12% of folium eucommiae, 6-12% of folium mori, 6-12% of semen plantaginis, 6-8% of herba lophatheri, 6-8% of pueraria mirifica powder, 2-5% of pelargonium graveolens and 2-5% of sanguisorba minor.

3. The gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout according to claim 2, wherein the pharmaceutical composition is prepared by mixing the following raw materials in percentage by mass:

60% of gynostemma pentaphyllum, 10% of folium eucommiae, 10% of folium mori, 4% of semen plantaginis, 4% of herba lophatheri, 4% of pueraria mirifica powder, 4% of pelargonium graveolens and 4% of sanguisorba minor.

4. The gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout according to claim 1, wherein the gynostemma pentaphyllum is prepared by mixing diploid gynostemma pentaphyllum leaves and tetraploid gynostemma pentaphyllum leaves.

5. The gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout according to claim 4, wherein a mass ratio of the diploid gynostemma pentaphyllum leaves to the tetraploid gynostemma pentaphyllum leaves is 2:

5 to 5;

2.

6. The gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout according to claim 5, wherein the mass ratio of the diploid gynostemma pentaphyllum leaves to the tetraploid gynostemma pentaphyllum leaves is 1:

1.

7. The gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout according to claim 1, wherein the pharmaceutical composition is prepared into tablets, pills, dissolved medicines, granules and powder.

8. An application of the gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout according to claim 1, wherein the pharmaceutical composition is used for preventing and treating hyperlipidemia, hypertension, hyperglycemia and hyperuricemia.